BioLargo (BLGO) Stock Price
BioLargo Price
Over the last 18 years BioLargo grew revenue by 28.9% annually, reaching 7.77 M USD. For BioLargo, the net margin of -151.7% is up versus -279.7% a few years ago.
BioLargo stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
BioLargo business model & stock analysis
Frequently asked questions about BioLargo
BioLargo Inc is a diversified environmental company focused on developing innovative technologies to address various global challenges. The business model of BioLargo Inc revolves around commercializing and licensing its proprietary technologies in areas such as water and air treatment, advanced wound care, and animal health. The company combines research, development, and commercialization to bring sustainable solutions to market. BioLargo Inc aims to create value for its shareholders by developing and marketing cost-effective and efficient products that provide significant benefits to industries and communities alike.
BioLargo Inc is primarily active in the fields of water treatment, environmental sustainability, and industrial solutions.
The main competitors of BioLargo Inc in the market are [competitor 1], [competitor 2], and [competitor 3]. These companies have established a strong presence in the [relevant industry] sector, competing with BioLargo Inc on various fronts. However, BioLargo Inc has continuously demonstrated its unique competitive advantage through its innovative [products/services] and commitment to [industry-specific goals]. With its extensive expertise and strategic initiatives, BioLargo Inc remains a formidable player in the market, consistently striving for growth and market leadership.
BioLargo Inc is a globally recognized company specializing in innovative water and environmental technologies. Established in 1989, BioLargo has dedicated years of research and development to create cutting-edge products aimed at solving some of the world's biggest challenges, including clean water availability and air quality. The company is renowned for its proprietary technology called Advanced Oxidation System (AOS), which effectively eliminates contaminants in water with high efficiency. With a strong commitment to sustainability and environmental responsibility, BioLargo continues to revolutionize industries such as water treatment, oil and gas, food processing, and more. The company's relentless pursuit of excellence positions BioLargo as a leader in providing transformative solutions for a healthier planet.
BioLargo Inc has achieved significant milestones throughout its history. It has developed innovative and sustainable technologies for various industries. Some notable achievements include the commercialization of its highly effective odor control products, such as CupriDyne Clean, which addresses odor issues across multiple sectors. The company has also successfully developed and patented its AOS water treatment system, which offers cost-effective and efficient solutions for contaminated water treatment. Furthermore, BioLargo has formed strategic partnerships and collaborations with leading organizations, enhancing its market reach and potential. These milestones demonstrate BioLargo Inc's commitment to finding innovative solutions for environmental challenges and establishing itself as a leader in its industry.
BioLargo Inc primarily operates in the United States. As a leading environmental engineering company, BioLargo provides innovative solutions for air and water pollution control, odor and moisture management, and sustainable energy technologies. The company's headquarters is located in California, with operations and partnerships across different states in the U.S. BioLargo Inc is focused on delivering cost-effective, scalable, and eco-friendly solutions to address major environmental challenges.
BioLargo Inc represents a commitment to innovation, sustainability, and environmental responsibility. The company's corporate philosophy is centered around providing cutting-edge solutions for water and air quality challenges. BioLargo believes in developing and commercializing advanced technologies that address crucial global issues, such as pollution, water scarcity, and climate change. With a focus on research and development, BioLargo strives to create sustainable and cost-effective products that improve the quality of life for people and the planet. As a leader in environmental solutions, BioLargo Inc continues to demonstrate its dedication to making a positive impact on the world through its values and corporate philosophy.
7 analysts currently rate the BioLargo stock: 6 recommend buying, 1 holding and 0 selling. For 2026, analysts expect BioLargo to generate revenue of 5.23 M USD and earnings per share of -0.05 USD.
Converted at the current exchange rate, the BioLargo share trades at 0.06 EUR (0.07 USD).
BioLargo Inc is an innovative company specializing in the development and marketing of environmentally friendly technologies. The company's business model is designed to create a sustainable future by providing solutions to some of the world's most urgent environmental problems. The company operates in three business segments: BioLargo Water, BioLargo Engineering, and BioLargo Sciences. Each division offers specialized technologies and products tailored to customer needs. BioLargo Water specializes in water treatment and desalination. The company has developed an award-winning technology called AOS, which is one of the most effective in the market. AOS stands for Advanced Oxidation System and uses a unique combination of ozone and ultraviolet light to achieve high water quality. The company also offers products such as water filters and desalination systems. BioLargo Engineering focuses on solving environmental engineering problems. It provides specialized engineering services and technical consulting to customers experiencing issues in their facilities. The company has developed a unique method to disinfect air streams without the release of harmful chemicals. The technology is called CupriDyne Clean and aims to control odors and VOCs in the air. BioLargo Sciences specializes in the development of technologies for the medical and healthcare industries. The company specializes in combating infectious diseases and biological threats. It has developed a patented technology called Clyraguard, which provides long-lasting disinfection. The company also offers products such as hand sanitizers and mouth rinses. BioLargo Inc is an environmentally-focused company that has developed multiple patented technologies in the fields of environmental engineering, health, and medicine. The company strives to offer customers effective and environmentally friendly solutions, making the planet a better place. The company has a track record of success stories, such as successfully implementing the AOS technology in a Canadian gold mine to clean wastewater. It has also improved the process of air disinfection in poultry farms, leading to improved quality of life for the animals. BioLargo Inc has an experienced leadership team composed of experts from various fields, including engineers, scientists, entrepreneurs, and environmentalists. The management team has a strong vision for the future and is working hard to achieve their goals. Overall, BioLargo Inc offers a wide range of environmentally friendly technologies and products. The company aims to provide customers with effective and safe solutions to solve some of the world's most urgent environmental problems.
The expected revenue of BioLargo is 5.23 M USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of BioLargo is -15.35 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of BioLargo is currently -1.45. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the BioLargo stock.
The price-to-sales ratio (P/S) of BioLargo is currently 4.25. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the BioLargo stock.
The Eulerpool Quality Score for BioLargo is 4/10.
The ISIN of BioLargo is US09065A1007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of BioLargo is A0MLEC. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of BioLargo is BLGO. The ticker symbol is used to trade BioLargo shares on the stock exchange.
BioLargo stock
BioLargo Peer Group
BioLargo Ticker
BioLargo FIGI
All fundamentals and in-depth analysis of BioLargo
Our stock analysis for BioLargo stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioLargo. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.